Your browser doesn't support javascript.
loading
Counteracting aldosterone in cardiorenal disease in type 2 diabetes through finerenone administration / Contrarrestar la aldosterona en la enfermedad cardiorrenal en la diabetes tipo 2 mediante la administración de finerenona
Ruilope, L. M; Ruiz-Hurtado, G.
Affiliation
  • Ruilope, L. M; Hospital Universitario 12 de Octubre. Institute of Research i+12. European University of Madrid. Madrid. Spain
  • Ruiz-Hurtado, G; Hospital Universitario 12 de Octubre. Institute of Research i+12. Cardiorenal Translational Laboratory. Madrid. Spain
Hipertens. riesgo vasc ; 40(2): 55-57, abr.-jun. 2023.
Article in English | IBECS | ID: ibc-220586
Responsible library: ES1.1
Localization: ES15.1 - BNCS
Subject(s)
Search on Google
Add to My VHL
Print
XML

Collection: National databases / Spain Database: IBECS Main subject: Diabetes Mellitus, Type 2 / Aldosterone Limits: Humans Language: English Journal: Hipertens. riesgo vasc Year: 2023 Document type: Article Institution/Affiliation country: Hospital Universitario 12 de Octubre/Spain
Search on Google
Add to My VHL
Print
XML

Collection: National databases / Spain Database: IBECS Main subject: Diabetes Mellitus, Type 2 / Aldosterone Limits: Humans Language: English Journal: Hipertens. riesgo vasc Year: 2023 Document type: Article Institution/Affiliation country: Hospital Universitario 12 de Octubre/Spain